Search
Patexia Research
Case number 2018-2220

Nevro Corp. v. Boston Scientific Corp. > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 NEVRO CORP. v. BOSTON SCIENTIFIC CORP. [OPINION] [precedential] (0)
May 18, 2020 72 Mandate issued to the United States District Court for the Northern District of California. Service as of this date by the Clerk of Court. [695252] [18-2220, 18-2349] [JAB] [Entered: 05/18/2020 11:31 AM] (1)
Apr 23, 2020 71 Bill of Costs for Appellant Nevro Corp.. Service: 04/23/2020 by email. [689583] [18-2220] [Deanne Maynard] [Entered: 04/23/2020 04:38 PM] (0)
Apr 9, 2020 70 JUDGMENT. VACATED AND REMANDED. Terminated on the merits after oral argument. COSTS: Costs taxed against Cross-appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [685516] [18-2220, 18-2349] [JAB] [Entered: 04/09/2020 10:10 AM] (1)
Apr 9, 2020 69 OPINION filed for the court by Moore, Circuit Judge; Taranto, Circuit Judge and Chen, Circuit Judge. Precedential Opinion. [685515] [18-2220, 18-2349] [JAB] [Entered: 04/09/2020 10:09 AM] (17)
Dec 2, 2019 68 Submitted after ORAL ARGUMENT by Ms. Deanne Maynard for Nevro Corp. and Matthew Wolf for Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Panel: Judge: Moore , Judge: Taranto , Judge: Chen. [653061] [JCP] [Entered: 12/02/2019 10:14 AM] (0)
Nov 15, 2019 67 Response to notice of oral argument from the Appellant Nevro Corp.. [649590] [18-2220] [Deanne Maynard] [Entered: 11/15/2019 10:13 AM] (3)
Nov 15, 2019 66 Response to notice of oral argument from the Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. [649583] [18-2220] [Matthew Wolf] [Entered: 11/15/2019 10:04 AM] (3)
Oct 21, 2019 65 NOTICE OF ORAL ARGUMENT. Panel: 1912A. Case scheduled December 2, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 11/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [643390] [JAB] [Entered: 10/21/2019 12:25 PM] (2)
Aug 30, 2019 64 The following conflict dates submitted by Attorney Matthew Wolf for Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation have been accepted by the court: 11/04/2019, 01/09/2019, 01/10/2019, 02/03/2019, 02/04/2019, 02/05/2019, 02/06/2019, 02/07/2019. [632482] [MJL] [Entered: 08/30/2019 04:29 PM] (0)
Aug 28, 2019 63 Notice from Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation regarding conflicts with oral argument. Service: 08/28/2019 by email. [631732] [18-2220] [Matthew Wolf] [Entered: 08/28/2019 03:24 PM] (4)
Aug 6, 2019 62 Amended Certificate of Interest for Appellant Nevro Corp.. Service: 08/06/2019 by email. [626467] [18-2220] [Deanne Maynard] [Entered: 08/06/2019 05:11 PM] (3)
Jul 2, 2019 61 6 paper copies of the Corrected Confidential Joint Appendix Brief (Vol. I - V) [51] received from Appellant Nevro Corp. and Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. [618597] [CJF] [Entered: 07/02/2019 01:55 PM] (0)
Jul 2, 2019 60 6 paper copies of the Reply Brief [37] received from Appellant Nevro Corp.. [618592] [CJF] [Entered: 07/02/2019 01:53 PM] (0)
Jun 28, 2019 59 6 paper copies of the Corrected Reply Brief [42] received from Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. [617969] [CJF] [Entered: 07/01/2019 07:36 AM] (0)
Jun 28, 2019 58 6 paper copies of the Opening Response Brief [32] received from Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. [617968] [CJF] [Entered: 07/01/2019 07:35 AM] (0)
Jun 28, 2019 57 The following conflict dates submitted by Attorney Deanne Maynard for Appellant Nevro Corp. have been accepted by the court: 10/04/2019. [617850] [JAB] [Entered: 06/28/2019 03:22 PM] (0)
Jun 28, 2019 56 Notice from Appellant Nevro Corp. regarding conflicts with oral argument. Service: 06/28/2019 by email. [617834] [18-2220] [Deanne Maynard] [Entered: 06/28/2019 02:59 PM] (4)
Jun 28, 2019 55 The following conflict dates submitted by Attorney Matthew Wolf for Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation have been accepted by the court: 02/03/2020, 02/04/2020, 02/05/2020, 02/06/2020, 02/07/2020. [617722] [JAB] [Entered: 06/28/2019 10:58 AM] (0)
Jun 28, 2019 54 Notice from Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation regarding conflicts with oral argument. Service: 06/28/2019 by email. [617687] [18-2220] [Matthew Wolf] [Entered: 06/28/2019 10:17 AM] (3)
Jun 26, 2019 53 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The notice of conflict with oral argument is due on or before 07/03/2019. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [617171] [TAM] [Entered: 06/26/2019 03:31 PM] (1)
Jun 26, 2019 52 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [617168] [TAM] [Entered: 06/26/2019 03:30 PM] (0)
Jun 20, 2019 51 MODIFIED ENTRY: CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Nevro Corp. and Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Number of Pages: 537. Service: 06/20/2019 by email, US mail. [615906]--[Edited 06/26/2019 by TAM - compliance review complete] [Deanne Maynard] [Entered: 06/20/2019 04:50 PM] (0)
Jun 20, 2019 50 MODIFIED ENTRY: CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Nevro Corp. and Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Number of Pages: 1923. Service: 06/20/2019 by US mail, email. [615904]--[Edited 06/26/2019 by TAM - compliance review complete] [Deanne Maynard] [Entered: 06/20/2019 04:47 PM] (0)
Jun 20, 2019 49 MODIFIED ENTRY: CORRECTED JOINT APPENDIX FILED for Nevro Corp. and Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Number of Pages: 2327. Service: 06/20/2019 by email. [615892] --[Edited 06/26/2019 by TAM - compliance review complete] [Deanne Maynard] [Entered: 06/20/2019 04:14 PM] (2327)
Jun 13, 2019 48 NOTICE OF NON-COMPLIANCE: The submissions of Appellant Nevro Corp. and Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation, Joint Appendix and Confidential Joint Appendix [43], [44], [45], are not in compliance with the rules of this court (see attached). Compliant document due on 06/20/2019. Service as of this date by the Clerk of Court. [613872] [TAM] [Entered: 06/13/2019 11:37 AM] (2)
Jun 10, 2019 47 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Nevro Corp.. Service: 06/10/2019 by email. [612906] [18-2220] [Deanne Maynard] [Entered: 06/10/2019 05:34 PM] (4)
Jun 10, 2019 46 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Nevro Corp. and Cross-Appellants Boston Scientific Neuromodulation Corporation and Boston Scientific Corporation. Service: 06/10/2019 by email. [612905] [18-2220] [Deanne Maynard] [Entered: 06/10/2019 05:33 PM] (3)
Jun 10, 2019 45 FILED from Appellant Nevro Corp. and Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Title: CONFIDENTIAL JOINT APPENDIX. Service: 06/10/2019 by email. [612903] [18-2220] This document is non-compliant. See Doc No.[48] [Deanne Maynard] [Entered: 06/10/2019 05:31 PM] (0)
Jun 10, 2019 44 FILED from Appellant Nevro Corp. and Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Title: CONFIDENTIAL JOINT APPENDIX. Service: 06/10/2019 by email. [612901] [18-2220] This document is non-compliant. See Doc No.[48] [Deanne Maynard] [Entered: 06/10/2019 05:28 PM] (0)
Jun 10, 2019 43 FILED from Appellant Nevro Corp. and Cross-Appellants Boston Scientific Neuromodulation Corporation and Boston Scientific Corporation. Title: JOINT APPENDIX. Service: 06/10/2019 by email. [612900] [18-2220] This document is non-compliant. See Doc No.[48] [Deanne Maynard] [Entered: 06/10/2019 05:20 PM] (2327)
Jun 6, 2019 42 MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED for Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Number of Pages: 19. Service: 06/06/2019 by email. [612156] --[Edited 06/10/2019 by TAM - compliance review complete] [Matthew Wolf] [Entered: 06/06/2019 03:37 PM] (26)
Jun 5, 2019 41 NOTICE OF NON-COMPLIANCE: The submission of Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation, Reply Brief [40], is not in compliance with the rules of this court (see attached). Compliant document due on 06/12/2019. Service as of this date by the Clerk of Court. [611755] [TAM] [Entered: 06/05/2019 02:15 PM] (2)
Jun 3, 2019 40 FILED from Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Title: REPLY BRIEF. Service: 06/03/2019 by email. [611145] [18-2220] This document is non-compliant. See Doc No.[41] [Krista Carter] [Entered: 06/03/2019 08:12 PM] (26)
Apr 18, 2019 39 **TEXT ONLY** ORDER granting motion to extend time to file Cross-Appellants' reply brief [38] filed by Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Brief due 06/03/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [601136] [TAM] [Entered: 04/18/2019 08:32 AM] (0)
Apr 17, 2019 38 MOTION of Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation to extend the time to 06/03/2019 to file the 30 day extension. [Consent: unopposed]. Service: 04/17/2019 by email. [601036] [18-2220]--[Edited 04/17/2019 by JCA to reflect correct service date and to add party filers] [Krista Carter] [Entered: 04/17/2019 03:00 PM] (10)
Apr 12, 2019 37 MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Nevro Corp. Number of Pages: 56. Service: 04/12/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [599785] --[Edited 04/15/2019 by TAM - compliance review complete] [Deanne Maynard] [Entered: 04/12/2019 03:51 PM] (68)
Mar 28, 2019 36 **TEXT ONLY** ORDER granting motion to extend time to file Appellant's reply brief [35] filed by Appellant Nevro Corp. Brief is due 04/12/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [596072] [TAM] [Entered: 03/28/2019 09:01 AM] (0)
Mar 22, 2019 35 MOTION of Appellant Nevro Corp. to extend the time to 04/12/2019 to file the Response/Reply Brief currently due 3/29/2019. [Consent: unopposed]. Service: 03/22/2019 by email. [594832] [18-2220] [Deanne Maynard] [Entered: 03/22/2019 09:05 AM] (8)
Feb 26, 2019 34 **TEXT ONLY** ORDER granting motion to extend time to file Appellant's reply brief [33] filed by Appellant Nevro Corp. Reply brief is due 03/29/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [588535] [TAM] [Entered: 02/26/2019 08:22 AM] (0)
Feb 19, 2019 33 MOTION of Appellant Nevro Corp. to extend the time to 03/29/2019 to file the Response/Reply Brief currently due 2/26/2019. [Consent: unopposed]. Service: 02/19/2019 by email. [587129] [18-2220] [Deanne Maynard] [Entered: 02/19/2019 03:43 PM] (8)
Jan 17, 2019 32 MODIFIED ENTRY: BRIEF FILED for Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Number of Pages: 60. Service: 01/17/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [579191] --[Edited 02/06/2019 by MMA - Reason: compliance review complete] [Matthew Wolf] [Entered: 01/17/2019 11:50 PM] (71)
Nov 20, 2018 31 6 paper copies of the Opening Brief [29] received from Appellant Nevro Corp.. [566687] [CJF] [Entered: 11/20/2018 11:22 AM] (0)
Nov 15, 2018 30 **TEXT ONLY** ORDER granting motion to extend time to file principal brief [28]. Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation brief due 01/17/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [565320] [SJ] [Entered: 11/15/2018 01:16 PM] (0)
Nov 14, 2018 28 MOTION of to extend the time to 01/17/2018 to file the Defendants-Cross-Appellants Principal and Response Brief. [Consent: unopposed]. Service: 11/14/2018 by email. [564958] [18-2220] [Krista Carter] [Entered: 11/14/2018 04:30 PM] (9)
Nov 8, 2018 29 BRIEF FILED for Appellant Nevro Corp. [27]. Number of Pages: 66. Service: 11/08/2018 by email. The paper copies of the brief should be received by the court on or before 11/26/2018. Cross-Appellants Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation brief is due 12/18/2018. [565317] [SJ] [Entered: 11/15/2018 01:12 PM] (341)
Nov 8, 2018 27 TENDERED from Appellant Nevro Corp.. Title: OPENING BRIEF. Service: 11/08/2018 by email. [563721] [18-2220] [Deanne Maynard] [Entered: 11/08/2018 05:49 PM] (341)
Oct 4, 2018 26 **TEXT ONLY** ORDER granting motion to extend time to file principal brief [25] filed by Appellant Nevro Corp. Brief is due 11/08/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [554933] [SJ] [Entered: 10/04/2018 02:34 PM] (0)
Oct 2, 2018 25 MOTION of Appellant Nevro Corp. to extend the time to 11/08/2018 to file the Opening Brief currently due 10/09/2018. [Consent: unopposed]. Service: 10/02/2018 by email. [554127] [18-2220] [Michael Jacobs] [Entered: 10/02/2018 12:38 PM] (8)
Oct 1, 2018 24 Entry of appearance for Eric C. Pai as of counsel for Appellant Nevro Corp.. Service: 10/01/2018 by email. [553900] [18-2220] [Eric Pai] [Entered: 10/01/2018 05:58 PM] (2)
Sep 10, 2018 23 Official caption revised to reflect cross-appeal by Boston Scientific. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [548367] [SJ] [Entered: 09/10/2018 11:21 AM] (0)
Sep 10, 2018 22 Note to file: The following cases are associated:18-2220 (lead) with 18-2349 (cross). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [548366] [18-2220, 18-2349] [SJ] [Entered: 09/10/2018 11:20 AM] (0)
Sep 7, 2018 21 Entry of appearance for Ryan C. Morris as of counsel for Appellant Nevro Corp.. Service: 09/07/2018 by email. [548237] [18-2220] [Ryan Morris] [Entered: 09/07/2018 06:03 PM] (2)
Sep 7, 2018 20 Entry of appearance for Bradford J. Badke as of counsel for Appellant Nevro Corp.. Service: 09/07/2018 by email. [548236] [18-2220] [Bradford Badke] [Entered: 09/07/2018 06:02 PM] (2)
Sep 7, 2018 19 Entry of appearance for Carter G. Phillips as of counsel for Appellant Nevro Corp.. Service: 09/07/2018 by email. [548233] [18-2220] [Carter Phillips] [Entered: 09/07/2018 06:00 PM] (2)
Sep 7, 2018 18 Entry of appearance for Ching-Lee Fukuda as of counsel for Appellant Nevro Corp.. Service: 09/07/2018 by email. [548232] [18-2220] [Ching-Lee Fukuda] [Entered: 09/07/2018 05:58 PM] (2)
Aug 31, 2018 17 Entry of appearance for Seth W. Lloyd as of counsel for Appellant Nevro Corp.. Service: 08/31/2018 by email. [546701] [18-2220] [Seth Lloyd] [Entered: 08/31/2018 02:02 PM] (2)
Aug 24, 2018 16 Entry of appearance for Kenneth A. Kuwayti as of counsel for Appellant Nevro Corp.. Service: 08/24/2018 by email. [545436] [18-2220] [Kenneth Kuwayti] [Entered: 08/24/2018 06:39 PM] (2)
Aug 23, 2018 15 Entry of appearance for Bita Rahebi as of counsel for Appellant Nevro Corp.. Service: 08/23/2018 by email. [545123] [18-2220] [Bita Rahebi] [Entered: 08/23/2018 05:30 PM] (2)
Aug 23, 2018 14 Certificate of Interest for the Appellant Nevro Corp.. Service: 08/23/2018 by email. [545094] [18-2220] [Michael Jacobs] [Entered: 08/23/2018 04:38 PM] (3)
Aug 23, 2018 13 Docketing Statement for the Appellant Nevro Corp.. Service: 08/23/2018 by email. [545091] [18-2220] [Michael Jacobs] [Entered: 08/23/2018 04:36 PM] (4)
Aug 23, 2018 12 Entry of appearance for Brian R. Matsui as of counsel for Appellant Nevro Corp.. Service: 08/23/2018 by email. [545072] [18-2220] [Brian Matsui] [Entered: 08/23/2018 04:27 PM] (2)
Aug 23, 2018 11 Entry of appearance for Deanne E. Maynard as of counsel for Appellant Nevro Corp.. Service: 08/23/2018 by email. [545068] [18-2220] [Deanne Maynard] [Entered: 08/23/2018 04:25 PM] (2)
Aug 23, 2018 10 Entry of appearance for Michael A. Jacobs as principal counsel for Appellant Nevro Corp.. Service: 08/23/2018 by email. [545067] [18-2220] [Michael Jacobs] [Entered: 08/23/2018 04:22 PM] (2)
Aug 23, 2018 9 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [6], attorney entry of appearance Docket No. [5], attorney entry of appearance Docket No. [4], attorney entry of appearance Docket No. [3], attorney entry of appearance Docket No. [2], ERROR: the use of 'et al.' to identify parties is discouraged by the court. CORRECTION: future filings should separately list each party represented. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [544952] [SJ] [Entered: 08/23/2018 01:46 PM] (0)
Aug 22, 2018 8 Docketing Statement for the Appellees Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Service: 08/22/2018 by email. [544800] [18-2220] [Krista Carter] [Entered: 08/22/2018 09:44 PM] (4)
Aug 22, 2018 7 Certificate of Interest for the Appellees Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Service: 08/22/2018 by email. [544799] [18-2220] [Krista Carter] [Entered: 08/22/2018 09:42 PM] (3)
Aug 22, 2018 6 Entry of appearance for Krista M. Carter as of counsel for Appellees Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Service: 08/22/2018 by email. [544798] [18-2220] [Krista Carter] [Entered: 08/22/2018 09:41 PM] (2)
Aug 22, 2018 5 Entry of appearance for Thomas T. Carmack as of counsel for Appellees Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Service: 08/22/2018 by email. [544797] [18-2220] [Thomas Carmack] [Entered: 08/22/2018 09:38 PM] (2)
Aug 22, 2018 4 Entry of appearance for Edward Han as of counsel for Appellees Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Service: 08/22/2018 by email. [544796] [18-2220] [Edward Han] [Entered: 08/22/2018 09:35 PM] (2)
Aug 22, 2018 3 Entry of appearance for Marc A. Cohn as of counsel for Appellees Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Service: 08/22/2018 by email. [544795] [18-2220] [Marc Cohn] [Entered: 08/22/2018 09:33 PM] (2)
Aug 22, 2018 2 Entry of appearance for Matthew M. Wolf as principal counsel for Appellees Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation. Service: 08/22/2018 by email. [544794] [18-2220] [Matthew Wolf] [Entered: 08/22/2018 09:30 PM] (2)
Aug 9, 2018 1 Appeal docketed. Received: 08/03/2018. [541667]Entry of Appearance due 08/23/2018. Certificate of Interest is due on 08/23/2018. Docketing Statement due 08/23/2018. Appellant/Petitioner's brief is due 10/09/2018. [SJ] [Entered: 08/09/2018 09:34 AM] (89)
Menu